We’ve just wrapped up the EORTC 2026 Strategy Meeting!
Two inspiring days bringing global leaders together to strengthen independent, patient‑centred clinical cancer research.
Grateful for the collaboration and insight.
🔜 Stay tuned!
#EORTC #ClinicalResearch #CancerResearch
🆕 Published in The Oncologist:
New results from the SPARTA (GIMEMA–EORTC 1621‑QLG‑LG) study examine quality of life and lifestyle behaviours in long‑term AML survivors, offering essential insights for patient‑centred care.
🔗 www.eortc.org/publications/
#CancerResearch #AML #EORTC @qol.eortc.org
🚀 Join #EORTC as an Engagement & Partnerships Officer (Philanthropy)!
Build a pipeline of HNWIs, steward donors, support campaigns, and contribute to legacy giving.
3–6 yrs fundraising/relationship mgmt experience? Strong communicator?
👉 eortc.org/job/engageme...
#Hiring
💪 We continue our strong EORTC presence at #ESMORareCancers26, sharing new evidence on QoL, molecular profiling and treatment innovation in rare cancers.
Tomorrow, look out for Tetsuya Sekita’s poster on surgical quality in retroperitoneal liposarcoma.
#EORTC #RareCancers
👏 Proud to have our Scientific Director ,Saskia Litière, representing EORTC today at #ECR2026, contributing to the session on real‑world imaging biomarkers.
Great discussions on how imaging is evolving in clinical research and practice.
#EORTC #MedicalImaging #CancerResearch
Key EORTC 2026 Oncology Events Across Europe
@eortc.org
oncodaily.com/voices/eortc...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #EORTC
Few Days Left to Apply for the 26th Workshop on Methods in Clinical Cancer Research – EORTC
@eortc.org
oncodaily.com/voices/eortc...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #EORTC #MCCR
EORTC - Early Career Investigator Programme on International Day of Education
@eortc.org
oncodaily.com/voices/early...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #EORTC
The final analysis of the CATNON trial is now published in The Lancet Oncology.
This landmark study helps define a new standard of care for patients with 1p/19q non-codeleted anaplastic glioma, building on results presented at #EANO2025.
🔗 https://ow.ly/WpKF50XWa0G
#EORTC #CATNON #NeuroOncology
EORTC - Coutndown Begins for the 2026 MCCR Workshop
@eortc.org
oncodaily.com/voices/eortc...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #EORTC #MCCR #MCCRWorkshop
📢 Don’t miss the EORTC webinar Patient Preferences Matter, happening this Friday, 9 January 2026.
🔗 For more information: www.eortc.org/event/joint-...
#PatientPreferences #CancerResearch #EORTC #ClinicalTrials
📢 Our December EORTC Newsletter is out!
Featuring key milestones, research highlights, and upcoming initiatives.
👉 Read the latest edition: us2.campaign-archive.com.
#CancerResearch #EORTC #Oncology
📢 Registration is now open!
Join us on 9 January 2026 for the EORTC webinar Patient Preferences Matter.
🔗 Register here: www.eortc.org/event/joint-...
#PatientPreferences #CancerResearch #EORTC #ClinicalTrials
📢 New EORTC publication!
Systemic chemo for CRCLM:
➡️ Better PFS & OS than surgery alone
➡️ Strongest benefit in synchronous cases
🔗 Full article: www.eortc.org/publications/
#CancerResearch #EORTC #Oncology
Medical Doctor Fellowship Opportunity with the RECIST Working Group at EORTC
@eortc.org
oncodaily.com/voices/docto...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #EORTC #RECIST
Older adults are most affected by cancer, yet often excluded from trials. Young patients face unique challenges too.
At #EORTC, we’re committed to #InclusiveTrials for ALL ages.
On #WCD, we renewed our promise: #LeavingNoCancerPatientBehind.
👉Donate here: donate.eortcresearchfund.org/eoy/~my-dona...
The #EORTC Lung Cancer Group held its autumn meeting last Friday to review projects and set research priorities.
This #LungCancerAwarenessMonth, we highlight how collaboration drives progress for patients.
🎥 Watch the message from Chair Jordi Remon Masip.
#ClinicalResearch
SISAQOL-IMI Publishes Key Paper and Launches Online Materials to Advance PROs in Cancer Clinical Trials – EORTC
@eortc.org
oncodaily.com/voices/sisaq...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #EORTC #SISAQOL-IMI
👏 Earlier today at ISPOR Europe, our CEO Denis Lacombe moderated the plenary session “Pragmatic Trials — Bridging Research and Real-World Care”.
🔗 Read more: www.eortc.org/blog/2025/11...
#ISPOR #ClinicalResearch #EORTC #CancerCare #PragmaticTrials
🤝 We would like to thank all our contributors and supporters for the incredible support of Patient Days 2025, which took place last week.
Your engagement made it a truly meaningful event for everyone involved.
#PatientDays #EORTC
🎉 What a day at #EORTC #PatientDays!
Day 1 was packed with energy, empathy and honest round table talks.
Thanks to all who joined, your voices are shaping the future of cancer care.
👋 See you tomorrow!
🔗https://www.eortc.org/event/patient-days-2025/?tab=1
#CancerCare #PatientEngagement #Oncology
📢 New insights from PEACE-1
This post-hoc analysis examines how adjusting for abiraterone-prednisone cross-over impacts survival outcomes in de novo mCSPC.
A key step in refining trial interpretation.
🔗 Read more: www.eortc.org/publications/
#PEACE1 #ProstateCancer #ClinicalTrials #EORTC
Cancer Vaccines in Focus at AACR-NCI-EORTC Conference
@theaacr.bsky.social @eortc.org
oncodaily.com/voices/cance...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #AACR #NCI #EORTC #CancerVaccines
📢 New publication alert!
EORTC’s RENALUT trial explores [177Lu]Lu-PSMA-617 in metastatic ccRCC. The protocol summary is now out in European Urology Oncology, highlighting radioligand therapy’s potential.
🔗 www.eortc.org/publications/
#EORTC #RENALUT #ccRCC
EORTC - Advancing Cancer Research with a Strong Focus on Patient Needs and Long-Term Outcomes
@eortc.org
oncodaily.com/voices/eortc...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #EORTC
📢 Today we highlight a critical topic at #ESMO25: Eva Blondeaux presents on discontinuation and attrition in first-line RCTs for solid tumors.
What do these trends mean for trial design and patient outcomes?
Don't miss it! 🕥 10:45–10:50
#CancerResearch #EORTC #Oncology
👉 We continue this exciting day at #ESMO25 with a spotlight on patient engagement!
Iryna Shakhnenko presents the EORTC framework, shaped by patients and professionals, to boost collaboration and improve research outcomes.
📢 Don't miss it!
#Oncology #PatientEngagement #EORTC
👏 Well done to Denis Lacombe for a compelling session today at #ESMO25!
Together, we’re shaping a future of cancer research that’s smarter and more inclusive.
#EORTC #CancerResearch #DEI #ClinicalTrials @myesmo.bsky.social
👏 Huge congrats to Madeline Pe for her fantastic presentation at #ESMO25!
Sharing key outcomes from the SISAQOL-IMI initiative and putting patient voices at the heart of cancer research.
Proud moment for EORTC! 📸
#QualityOfLife #EORTC #CancerResearch #GivingVoice2Patients @qol.eortc.org
📍We are in Berlin for #ESMO25. Come and visit us at our booth #S4040.
Don't miss EORTC's upcoming sessions, mini-oral sessions, posters and more. Stay tuned!
👉 More info: www.eortc.org/blog/2025/10...
@myesmo.bsky.social #EORTC #ClinicalTrials #CancerResearch #Oncology #TreatmentOptimisation
